Market Tracker

02/05 5:16pm ET

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

19.36
Delayed Data
As of Feb 05
 -0.93 / -4.58%
Today’s Change
17.52
Today|||52-Week Range
51.99
-45.69%
Year-to-Date
No recent news for ACADIA Pharmaceuticals Inc.

Today’s Trading

Previous close20.29
Today’s open19.90
Day’s range19.23 - 20.62
Volume2,686,737
Average volume (3 months)1,616,324
Market cap$2.3B
Dividend yield--
Data as of 4:00pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)-115.91%
Earnings growth (this year)-67.72%
Earnings growth (next 5 years)--
Revenue growth (last year)-89.52%
P/E ratioNM
Price/Sales25,730.20
Price/Book6.56

Competitors

 Today’s
change
Today’s
% change
MDCOMedicines Co-1.86-5.66%
RAREUltragenyx Pharmaceu...-0.41-0.76%
IPXLImpax Laboratories I...-1.14-3.27%
ICPTIntercept Pharmaceut...-3.83-3.74%
Data as of 4:00pm ET, 02/05/2016

Financials

Next reporting dateFebruary 25, 2016
EPS forecast (this quarter)-$0.41
Annual revenue (last year)$120.0K
Annual profit (last year)-$92.5M
Net profit margin-77,062.50%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stephen R. Davis
Vice President-Technology Development &
Operations
James A. Nash
Corporate headquarters
San Diego, California

Forecasts